Error: Could not add to watchlist. X

Generex Biotechnology Corp

+ Watchlist
GNBT:US
OTC US
0.010
USD
0.000
1.92%
As of 20:10:00 ET on 07/29/2015.
Open
0.010
Day Range
0.010 - 0.011
Volume
5,475,896
Previous Close
0.010
52Wk Range
0.010 - 0.039
1 Yr Return
-54.92%
Open
0.010
Day Range
0.010 - 0.011
Volume
5,475,896
Previous Close
0.010
52Wk Range
0.010 - 0.039
1 Yr Return
-54.92%
YTD Return
-7.27%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.001
Market Cap (m USD)
8.215
Shares Outstanding (m)
805.378
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.
ADDRESS
33 Harbour Square
Suite 202
Toronto, ON M5J 2G2
Canada
PHONE
1-416-364-2551
  • Mark A Fletcher
    Pres/CEO/Gen Cnsl
  • Stephen Fellows
    Chief Financial Officer
  • David A Brusegard
    COO/Secretary
  • Eric Von Hofe
    Vice President
  • Todd Falls
    Investor Relations
Show More